These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

757 related items for PubMed ID: 30426887

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cytological features of "noninvasive follicular thyroid neoplasm with papillary-like nuclear features" and their correlation with tumor histology.
    Maletta F, Massa F, Torregrossa L, Duregon E, Casadei GP, Basolo F, Tallini G, Volante M, Nikiforov YE, Papotti M.
    Hum Pathol; 2016 Aug; 54():134-42. PubMed ID: 27085556
    [Abstract] [Full Text] [Related]

  • 5. Systematic Review and Meta-analysis of the Impact of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) on Cytological Diagnosis and Thyroid Cancer Prevalence.
    Ruanpeng D, Cheungpasitporn W, Thongprayoon C, Hennessey JV, Shrestha RT.
    Endocr Pathol; 2019 Sep; 30(3):189-200. PubMed ID: 31338752
    [Abstract] [Full Text] [Related]

  • 6. Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma.
    Zhao L, Dias-Santagata D, Sadow PM, Faquin WC.
    Cancer Cytopathol; 2017 May; 125(5):323-331. PubMed ID: 28192645
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Ultrasound and cytological characteristics of non-invasive follicular thyroid neoplasm with papillary-like nuclear features compared to papillary carcinomas.
    Boursier L, Clerc Urmes I, Garon J, Klein M, Demarquet L.
    Ann Endocrinol (Paris); 2020 Feb; 81(1):28-33. PubMed ID: 32081363
    [Abstract] [Full Text] [Related]

  • 9. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): Implications for the risk of malignancy (ROM) in the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC).
    Zhou H, Baloch ZW, Nayar R, Bizzarro T, Fadda G, Adhikari-Guragain D, Hatem J, Larocca LM, Samolczyk J, Slade J, Rossi ED.
    Cancer Cytopathol; 2018 Jan; 126(1):20-26. PubMed ID: 28941185
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Suggesting the cytologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): A retrospective analysis of atypical and suspicious nodules.
    Strickland KC, Howitt BE, Barletta JA, Cibas ES, Krane JF.
    Cancer Cytopathol; 2018 Feb; 126(2):86-93. PubMed ID: 28914983
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. CLINICAL IMPACT OF NON-INVASIVE FOLLICULAR THYROID NEOPLASM WITH PAPILLARY-LIKE NUCLEAR FEATURES ON THE RISK OF MALIGNANCY IN THE BETHESDA SYSTEM FOR REPORTING THYROID CYTOPATHOLOGY: A META-ANALYSIS OF 14,153 RESECTED THYROID NODULES.
    Vuong HG, Tran TTK, Bychkov A, Jung CK, Nakazawa T, Kakudo K, Katoh R, Kondo T.
    Endocr Pract; 2019 May; 25(5):491-502. PubMed ID: 30657357
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. RISK OF MALIGNANCY IN THYROID CYTOLOGY: THE IMPACT OF THE RECLASSIFICATION OF NONINVASIVE FOLLICULAR THYROID NEOPLASM WITH PAPILLARY-LIKE NUCLEAR FEATURES (NIFTP).
    Ventura M, Melo M, Fernandes G, Carrilho F.
    Endocr Pract; 2019 Jul; 25(7):642-647. PubMed ID: 30865528
    [Abstract] [Full Text] [Related]

  • 19. Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features and Its Impact on the Risk of Malignancy in the Bethesda System for Reporting Thyroid Cytopathology: An Institutional Experience.
    Kim M, Kim JE, Kim HJ, Chung YR, Kwak Y, Park SY.
    J Pathol Transl Med; 2018 May; 52(3):171-178. PubMed ID: 29614546
    [Abstract] [Full Text] [Related]

  • 20. The influence of the reclassification of NIFTP as an uncertain tumour on risk of malignancy for the diagnostic categories according to the Bethesda system for reporting thyroid cytopathology.
    Kopczyński J, Suligowska A, Niemyska K, Palyga I, Walczyk A, Gąsior-Perczak D, Kowalik A, Hińcza K, Mężyk R, Góźdź S, Kowalska A.
    Endokrynol Pol; 2019 May; 70(3):232-236. PubMed ID: 30845342
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.